French Health Minister Xavier Bertrand has called for a report on the functioning of the self-medication - or over-the-counter drugs - market in France with a view to reversing the current contraction.
Non-prescription medicines account for between 4% and 6% of the total market - 350 million packs a year - or about 1.6 billion euros ($2.11 billion), according to the sector association Afipa. Sales went down 3% last year in contrast to the position in other European countries. The German self-medication segment, for example, accounts for 12% of the total market and is estimated to be worth 5.0 billion euros.
In contrast, French consumption of self-medication products is very low, with patients generally preferring to consult a doctor. Claude Le Pen, a French health economist, says that self-medication represents an economic potential far superior to that of generics and Afipa estimates that transferring 5% of current prescriptions to self-medication would save some 2.5 billion euros a year for the health funds.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze